FGFR1 expression and/or amplification has been linked to epithelial-mesenchymal transition and metastasis in other cancers, including lung cancer, bladder and urothelial cancer, and gastric cancer [[43], [44], [45], [46]]. Here, FGFR1 is linked to lung carcinoma.